We examined the association of accelerated progression of white matter hyperintensities (WMH) with mortality outcomes in 534 older subjects at risk for cardiovascular disease. Using brain magnetic resonance imaging, volume of WMH was measured 2 times in an average of 33 months apart. After the second magnetic resonance imaging, occurrence of death was recorded during 12 years of follow-up. In multivariable analyses, each mL/y increase in global WMH was associated with 1.22-fold (95% confidence interval [CI], 1.09e1.37) higher risk of all-cause mortality, 1.29-fold (95% CI, 1.06e1.56) higher risk of cardiovascular mortality, and 1.20-fold (95% CI, 1.02e1.40) higher risk of noncardiovascular mortality. Each mL/y increase in periventricular WMH was associated with 1.22-fold (95% CI, 1.08e37) higher risk of all-cause mortality and 1.24-fold (95% CI, 1.06e1.44) higher risk of noncardiovascular mortality. Conversely, deep cortical WMH was only associated with cardiovascular mortality (1.92-fold, 95% CI, 1.12e3.30). Accelerated progression of WMH is linked with mortality risk in old age. Progression of periventricular WMH associates with noncardiovascular mortality, whereas progression of deep cortical WMH associates with cardiovascular mortality.
Introduction
White matter hyperintensities (WMH) are commonly observed on brain magnetic resonance imaging (MRI) of older subjects (Soderlund et al., 2003) . Neuroimaging studies have shown that about 80 percent of older people from the general population have deep cortical WMH and >60 percent have periventricular WMH (de Leeuw et al., 2001) . Increasing evidence supports that higher loads of WMH are associated with adverse health outcomes (Debette and Markus, 2010) . Despite this evidence and given that prevalent WMH might basically reflect long-term vascular and inflammatory insults to the brain (Raz et al., 2012) , it is unknown whether rapid progression of WMH in old age is also associated with higher risk of mortality.
Previous studies have reported different neuropathological features for periventricular and deep cortical WMH and also showed that location of WMH is related to various clinical consequences (Kim et al., 2008) . For instance, periventricular (and not deep cortical) WMH is associated with impaired executive function and processing speed (Seo et al., 2012) , whereas subjects with depression have higher loads of deep cortical WMH (Sheline et al., 2008) . Studies on the association between WMH and mortality have mainly focused on total WMH, and it is unclear whether progression of WMH in different anatomical locations shows differential association in relation to all-cause, cardiovascular, and noncardiovascular mortality.
In this study, in a cohort of older subjects at risk for cardiovascular disease, we investigated whether rapid progression of WMH is linked with a higher risk of all-cause, cardiovascular, and noncardiovascular mortality. Furthermore, we tested whether periventricular and deep cortical WMH show different associations in relation to mortality outcomes.
Methods

Setting and participants
We included participants from the nested MRI substudy of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), a randomized clinical trial investigating the benefits of pravastatin on vascular outcomes (Shepherd et al., 1999) . Study participants were males or females aged 70e82 years with either pre-existing vascular diseases or with increased risk of vascular disease because of smoking, hypertension, or diabetes mellitus. Subjects with congestive heart failure (New York Heart Association class III/IV), significant arrhythmia, and cognitive impairment (Mini-Mental Score Examination score <24) were not recruited in the PROSPER study. Inclusion and exclusion criteria of the PROSPER study have been described in detail elsewhere (Shepherd et al., 1999) . A total of 554 Dutch participants who completed the trial underwent 2 successive MRI scans of the brain. The first MRI was during the placebo lead-in period and the second MRI after an average follow-up of 33 months (range: 35e44 months). In this study, we did not include 20 participants from the MRI substudy who had incomplete data for baseline and/or follow-up WMH. There was no significant difference between characteristics of the included participants and subjects with missing values. Because we previously reported that treatment with pravastatin does not influence WMH changes (ten Dam et al., 2005) and accelerated progression of total, subcortical and periventricular WMH were not related to pravastatin use (Supplementary Table 1) , participants were included from both pravastatin and placebo groups. In addition, analyses were adjusted for statin treatment. The institutional review board approved the protocol for the MRI study, and all participants gave written, informed consent.
MRI scanning
All imaging was performed on an MR system operating at field strength of 1.5 T (Philips Medical Systems, Best, the Netherlands were obtained from all subjects. The SIENAX (Structural Image Evaluation, using Normalization, of Atrophy for cross-sectional measurement) technique was used to obtain estimates of total brain parenchymal volume, gray matter and white matter volume. In summary, SIENAX starts by extracting brain and skull images from the single whole-head input data. The brain image is then affine-registered to Montreal Neurological Institute 152 space (by using the skull image to determine the registration scaling), done primarily to obtain the volumetric scaling factor to be used as normalization for head size (Smith et al., 2004) . Segmentation of WMH volume was performed automatically using Software for Neuro-Image Processing in Experimental Research, an in-house developed program for image processing (Admiraal-Behloul et al., 2005) . This segmentation was based on the T2-weighted and FLAIR images. WMH were defined as hyperintense lesions on both proton density and T2-weighted images. WMH connected to the lateral ventricles were labeled as periventricular WMH, and those not connected to the lateral ventricles were labeled as deep WMH. To correct for incidental inclusion of cerebrospinal fluid and gray matter, the automatically generated WMH segmentations were edited manually by 2 trained raters. Moreover, FLAIR hardcopies were used as a reference to rule out other pathogenesis. To prevent the possibility of over-reading WMH progression in a direct scan comparison setting, we analyzed the first and second MRIs in random order. Fifteen MRI scans were segmented twice to assess the intrarater and inter-rater reliability of the volumetric WMH measurements. Intraclass correlation coefficients for periventricular and deep WMH volumes were all 0.99 (van den Heuvel et al., 2006) . Rate of the progression of WMH was calculated by subtracting WMH volumes in the baseline session from WMH in the follow-up session divided by the years between 2 MRI assessments (mL/y).
Mortality
After the second MRI, participants were followed for occurrence of mortality until January 1, 2012 in a follow-up period of 12 years. 158 (22) 156 (22) 158 (22) 158 (21) 0.578 DBP, mmHg, mean (SD) 86 (11) 86 (11) 86 (11) 86 (10) We obtained dates of deaths from the Dutch civic registry and specific data on causes of death from Statistics Netherlands. In the Netherlands, death certificates are issued by the attending physician or medical examiner. Death certificates with underlying causes of death, supported by the medical records, are sent to the Central Bureau of Statistics. An underlying cause of death is defined as ''the disease or injury that initiated the train of morbid events leading directly to death or the circumstances of the accident or violence which produced the fatal injury''. The underlying cause of death is selected from a death certificate and coded according to the International Classification of Diseases and related disorders, 10th revision, 1992. The high reliability of this method for major causes of mortality has been established previously (Harteloh et al., 2010) . Coronary heart disease, cancers, cerebrovascular diseases, respiratory disorders, and dementia and/or neurodegenerative diseases are the main causes of death among older subjects in the Netherlands. All the coronary heart diseases and cerebrovascular accidents were categorized in the cardiovascular group and cancers, respiratory disorders, and neuropsychiatric diseases including dementia were regarded as noncardiovascular causes. Death due to cardiovascular mortality was classified as International Classification of Diseases, 10th revision codes I00eI99 and death due to other reasons recorded as noncardiovascular mortality.
Statistical analysis
Baseline characteristics of the study participants are reported as mean (standard deviation) for continuous variables and number (percentage) for categorical variables. Differences in characteristics of study participants in tertiles of WMH progression were tested by analysis of variance for continuous variables and Pearson c 2 test for categorical variables. In the whole group and in tertiles of WMH progression, all-cause, cardiovascular, and noncardiovascular mortality rates were calculated by dividing number of events to person-years at risk. To compare cumulative incidence of all-cause, noncardiovascular, and cardiovascular mortality in tertiles of WMH progression, Kaplan-Meier graphs were made and strata were compared with log-rank tests. We used Cox proportional hazard models to estimate risk of all-cause, noncardiovascular, and cardiovascular mortality associated with level of WMH progression. Cox regression models were fit with time to death as the outcome variables and WMH progression (mL/y) as the determinants. The analyses were conducted in 3 steps. In the first step, analyses were performed without any adjustment. In the second step, analyses were adjusted for age and sex, and in the final model analyses were adjusted for age, sex, education, body mass index, smoking, serum cholesterol, systolic blood pressure, antihypertensive medication, diabetes mellitus, statin treatment, history of vascular diseases (peripheral, cardiac, and cerebral), and WMH volume at baseline. Similarly, in a 3-step analysis, using linear regression models, we calculated the unadjusted and adjusted gray matter volumes in thirds of total WMH progression. In a sensitivity analysis, we excluded subjects who developed cardiovascular events and stroke between 2 MRI measurements to see whether the associations were independent of these events. All the analyses were carried out using SPSS software (version 20.0.0, SPSS Inc, Chicago, IL, USA).
Results
Mean age of participants was 74.5-year-old and 56.4% of them were male. Participants with more rapid progression of WMH were older (p < 0.001). The remainder of demographic and cardiovascular Fig. 1 . Cumulative mortality in relation to white matter hyperintensities (WMH) progression Kaplan-Meier curves for all-cause, noncardiovascular, and cardiovascular mortality in tertiles of progression in total white matter hyperintensities (mL/y). Table 1) . During follow-up period, 264 (49.4%) subjects died of whom 83 subjects died of cardiovascular causes and 179 subjects died of noncardiovascular causes. For 2 subjects causes of death were not identified. Incidence rates of all-cause, cardiovascular, and noncardiovascular mortality were 55.6, 17.5, and 37.7 per 1000 person-years, respectively. Total numbers of deaths in the low, middle, and high tertiles of WMH progression were 71 (26.9%), 85 (32.2%), and 108 (40.9%), respectively. Fig. 1 shows cumulative all-cause, cardiovascular, and noncardiovascular mortality in relation to tertiles of total WMH progression. In the multivariable adjusted model, each mL/y higher progression of total WMH was associated with 1.22-fold (95% CI: 1.09e1.37) higher risk of all-cause mortality. Each mL/y higher progression of total WMH was associated with 1.29-fold (95% CI: 1.06e1.56) higher risk of cardiovascular mortality and 1.20-fold (95% CI: 1.02e1.40) higher risk of noncardiovascular mortality (Table 2 ).
In the multivariable adjusted model, each mL/y higher progression of periventricular WMH was associated with 1.22-fold (95% CI: 1.08e1.37) higher risk of all-cause mortality (Table 3) . Despite a significant association between periventricular WMH progression and cardiovascular mortality in the crude and minimally adjusted models, we found no significant association in the multivariable model. In contrast, in the multivariable model, each mL/y higher progression of periventricular WMH was significantly associated with 1.24-fold (95% CI: 1.06e1.44) higher risk of noncardiovascular mortality.
There was no significant association between progression of deep cortical WMH and all-cause mortality (Table 4) . Similarly, progression of deep cortical WMH was not associated with noncardiovascular mortality. However, each mL/y higher progression of deep cortical WMH was associated with 1.92-fold (95% CI: 1.12e3.30) higher risk of cardiovascular mortality.
In an extra analysis, we tested whether more rapid progression of total WMH was associated with lower gray matter volumes in the follow-up MRI session. We observed that in the unadjusted model accelerated progression of WMH was associated with lower gray matter volume. However, after further adjustment for demographic and cardiovascular factors, progression of WMH was not associated with level of gray matter volumes (Supplementary Table 6 ). To test whether the associations between WMH progression and mortality outcomes were independent of cardiovascular and stroke events occurred between 2 MRI measurements, we performed a restricted analysis excluding subjects who developed cardiovascular events (n ¼ 56) or stroke (n ¼ 26) between 2 MRI measurements. This restricted analysis showed that exclusion of subjects with events did not essentially change the associations (Supplementary Tables 2e5).
Discussion
In this prospective study, we showed that accelerated progression of WMH is linked with subsequent risk of mortality in older subjects at risk for cardiovascular disease. We observed that progression of periventricular WMH was significantly associated with noncardiovascular mortality whereas progression of deep cortical WMH was associated with cardiovascular mortality.
There are a number of prospective studies that investigated the association between presence and volume of WMH with future risk of mortality. Bokura et al., showed that in neurologically normal adults, with mean age of 58-year-old, periventricular and not deep cortical WMH are associated with higher risk of mortality (Bokura et al., 2006) . In an analyses from the Framingham Offspring Study (mean age 62-year-old), participants with higher total WMH volume were shown to be at higher risk of mortality during 5.6 years of follow-up . Similarly, Ikram et al., showed that in community dwelling older adults higher global WMH volumes were related to higher risk of stroke and mortality (Ikram et al., 2009) . All these studies measured WMH once and did not report whether accelerated progression of WMH associates with higher risk of mortality in old age. Because single measurement of WMH in older age may reflect long-standing exposure to cardiovascular risk factors and inflammatory process, it is unclear whether development of new WMH in older adults is also of clinical significance. In this long-term follow-up study among subjects >70 years with repeated measurements of WMH, we demonstrated that accelerated accumulation of WMH detected on brain MRI, independent of baseline WMH volume and cardiovascular status and events, associates with future risk of all-cause, cardiovascular, and noncardiovascular mortality. Different explanations can be put forward for the association between WMH progression and risk of mortality. First, this association could be due to shared sociodemographic and vascular risk factors. However, in this study, we have seen that factors such as age, education, history of cardiovascular risk factors, and vascular events did not influence the associations. Another explanation could be that accelerated progression of WMH mirrors accelerated vascular damage in the whole body which puts subjects at risk of death. This explanation can particularly describe higher risk of cardiovascular mortality in relation to deep cortical WMH. Previous reports have also shown that deep cortical WMH are stronger predictors for manifestations of cerebral small vessel disease such as lacunar infarcts (Gouw et al., 2008) . White matter integrity plays a crucial role in normal functioning of the brain (Chanraud et al., 2010) . Several complex activities of the brain are coordinated with close interactions between different regions of the brain (Greicius et al., 2003) . The brain is involved not only in cognitive, sensory, and motor functions but also in regulation of homeostasis through endocrine and autonomic systems (Ulrich-Lai and Herman, 2009). Therefore, one explanation could be that accelerated changes in the brain might influence the whole body which ultimately increases risk of cardiovascular and noncardiovascular mortality. Although the latter explanation seems plausible, we cannot infer it merely from our observational data, and future work is needed to address how impaired white matter integrity affects homeostasis in the body. Collectively, it seems that no single mechanism can explain the observed associations.
Differential associations of periventricular and deep cortical WMH with noncardiovascular and cardiovascular mortality might reinforce findings of previous studies which showed that WMH in different brain regions have different pathophysiology as well as clinical consequences (Sachdev and Wen, 2005) . It has been suggested that periventricular WMH are more likely to develop because of chronic hemodynamic abnormalities, whereas deep WMH are more likely to be related to ischemic changes because of atherosclerosis or embolic events (Kim et al., 2008) . Areas where periventricular WMH are located receive their blood supply from noncollateralizing ventriculofugal arteries which makes them vulnerable to vascular insufficiency and decline in cerebral blood flow (Mandell et al., 2008; ten Dam et al., 2007) . In older subjects, several studies have shown that risk of cognitive impairment is preferentially associated with periventricular WMH compared with deep cortical WMH (Debette and Markus, 2010) . Conversely, depressive symptoms in old age have closer relation with deep cortical WMH rather than periventricular WMH (Thomas et al., 2002) which supports an ischemic basis for the link between deep cortical WMH and mood disorders. Despite these evidences, it should be emphasized that detailed information on specific causes of mortality is needed to better understand the mechanisms underlying the association of periventricular WMH with noncardiovascular mortality and the association of deep WMH with cardiovascular-related deaths.
Certain strengths and limitations of this study need to be acknowledged. Strengths of this study include long follow-up time, repeated measurements of WMH, and availability of data for a wide range of cardiovascular factors. As a limitation, we included older subjects at risk for cardiovascular disease which might limit extrapolation of the findings to general population of older subjects. Although a high proportion of older subjects have history of cardiovascular diseases or risk factors (Yusuf and Ounpuu, 2003) , future research are needed to test this research question in population-based studies. As another limitation, because of limited number of participants, we were only able to categorize the causes of mortality into 2 broad groups of cardiovascular and noncardiovascular mortality. Certainly, study of larger populations can provide the opportunity to specifically address the potential links between WMH accumulation and specific causes of death. It has been shown that development of WMH is preceded by microstructural changes in white matter which can be detected with diffusion tensor imaging studies (Salat et al., 2005) . Therefore, further studies need to address whether accelerated impairment in white matter integrity even before presence of WMH is related to adverse clinical outcomes and mortality.
In conclusion, we found that rapid progression of WMH identified on brain MRI is associated with higher risk of all-cause, cardiovascular, and noncardiovascular mortality in old age. These associations were independent of conventional cardiovascular risk factors and baseline load of WMH. These findings suggest that progression of WMH is an independent risk indicator for mortality in old age and, in addition to volume of WMH, location of WMH might guide clinicians toward specific strategies to prevent morbidities and mortalities in older subjects.
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